M3, Inc. (MTHRY)
OTCMKTS · Delayed Price · Currency is USD
6.59
-0.11 (-1.64%)
At close: Jan 6, 2026
M3, Inc. Market Cap
M3, Inc. has a market cap or net worth of $9.02 billion as of January 6, 2026. Its market cap has increased by 36.81% in one year.
Market Cap
9.02B
Enterprise Value
8.60B
Revenue
2.24B
Ranking
n/a
PE Ratio
29.07
Stock Price
$6.59
Market Cap Chart
Since September 16, 2004, M3, Inc.'s market cap has increased from 488.38M to 9.02B, an increase of 1,746.02%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 9.03B | -1.46% |
| Dec 30, 2025 | 9.16B | 51.84% |
| Dec 30, 2024 | 6.04B | -46.29% |
| Dec 29, 2023 | 11.24B | -38.99% |
| Dec 30, 2022 | 18.42B | -46.06% |
| Dec 30, 2021 | 34.15B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |